Procaps Group to Participate in the BTG Pactual LatAm CEO Conference
10/05/2022 - 10:15 AM
MIAMI and BARRANQUILLA, Colombia, Oct. 05, 2022 (GLOBE NEWSWIRE) -- Procaps Group (NASDAQ: PROC) (“Procaps”), a leading integrated LatAm healthcare and pharmaceutical conglomerate, today announced it will participate in the BTG Pactual LatAm CEO Conference being held at the InterContinental NY Barclays Hotel October 11-13, 2022.
Procaps Group Chief Executive Officer Rubén Minski, Chief Financial Officer Patricio Vargas, and Investor Relations Director Melissa Angelini will conduct in-person one-on-one meetings on October 11 and 12 during which they will discuss the pending acquisition of Grupo Somar, 2022 performance, and other strategic initiatives.
BTG Pactual LatAm CEO Conference Date: October 11-13, 2022 Location: New York, NY Format: In-person 1x1's and presentation Attendees: Chief Executive Officer Rubén Minski, Chief Financial Officer Patricio Vargas, Investor Relations Director Melissa Angelini
For more information on the BTG Pactual LatAm CEO Conference or to schedule a one-on-one meeting with Procaps Group management, please contact your conference representative or you may also email your request to ir@procapsgroup.com .
About Procaps Group Procaps Group, S.A. (“Procaps”) (NASDAQ: PROC) is a leading developer of pharmaceutical and nutraceutical solutions, medicines, and hospital supplies that reach more than 50 countries in all five continents. Procaps has a direct presence in 13 countries in the Americas and more than 5,300 employees working under a sustainable model. Procaps develops, manufactures, and markets over-the-counter (OTC) pharmaceutical products, prescription pharmaceutical drugs (Rx), nutritional supplements, and high-potency clinical solutions.
For more information, visit www.procapsgroup.com or Procaps’ investor relations website investor.procapsgroup.com .
Investor Contact: Melissa Angelini ir@procapsgroup.com +1 754 260-6476investor.procapsgroup.com
PROC Rankings
#4954 Ranked by Stock Gains
PROC Stock Data
Industry
Medicinal and Botanical Manufacturing
Sector
Manufacturing
Country
LU
City
Luxembourg City
About PROC
procaps group has experience in the development of pharmaceutical and nutraceutical solutions, medicines, and hospital supplies that reach more than 50 countries in all five continents. we have direct presence in 13 countries in latin america and we have more than 5,000 collaborators working under a sustainable model. we develop, manufacture, and market over-the-counter (otc) and prescription drugs, nutritional supplements and high-potential clinical solutions.